+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Assessing the impact of FDG-PET in the management of anal cancer



Assessing the impact of FDG-PET in the management of anal cancer



RadioTherapy and Oncology 87(3): 376-382



To assess the utility of FDG-PET in anal cancer for staging and impact on radiotherapy planning (RTP), response and detection of recurrent disease. Fifty histopathological anal cancer patients were reviewed between 1996 and 2006. The median age was 58 years (range 36-85) with 19 males:31females. Clinical assessment with CT was compared to PET. Impact on management, disease response, recurrence and metastases was evaluated. The non-PET staging was Stage I(8), Stage II(18), Stage III(22), and Stage IV(2)s. The primary was strongly FDG avid in 98% with non-excised tumors compared to CT (58%). PET upstaged 17% with unsuspected pelvic/inguinal nodal disease. Pre-treatment PET identified 11 additional by involved nodal groups in 48 patients causing RTP amendments in 19%. Post-treatment PETs at median 17 weeks (range 9-28) showed complete responses in 20 (80%) and 5 (20%) partial responses (PR). PRs were biopsy positive in 2 and negative in 3. Fifteen had follow-up scans of which all nine PETs detected recurrences were pathologically confirmed. Anal cancer is FDG-PET avid. PET upstages 17% and changes the RTP in 19%. PET can aid in anal cancer staging and identification of residual disease, recurrent/metastatic disease but warrants further prospective studies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051654387

Download citation: RISBibTeXText

PMID: 18453023

DOI: 10.1016/j.radonc.2008.04.003


Related references

Fdg-pet in anal cancer: Impact on staging and radiotherapeutic management. International Journal of Radiation Oncology*biology*physics 60: S421-S422, 2004

Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review. Journal of BUON 11(4): 523-527, 2007

Assessing the Utility of Anal Pap Smears for the Surveillance of Peri-Anal/Anal Canal Carcinoma Following Definitive Radiation Therapy. International Journal of Radiation Oncology*biology*physics 81(2): S571-S572, 2011

The Impact of Tumour Distance From the Anal Verge on Clinical Management and Outcomes in Patients Having a Curative Resection for Rectal Cancer. Journal of Gastrointestinal Surgery 21(12): 2056-2065, 2017

Screening and management of anal dysplasia and anal cancer in HIV-infected patients: a guide for practice. Journal of the Association of Nurses in Aids Care 21(5): 408-416, 2010

Diagnosis and management of anal intraepithelial neoplasia and anal cancer. Bmj 343: D6818, 2011

High-resolution anoscopy or expectant management for anal intraepithelial neoplasia for the prevention of anal cancer: is there really a difference?. Diseases of the Colon and Rectum 58(1): 53-59, 2015

Assessing the impact of evidence-based continuing education on nonpharmacologic management of cancer pain. Journal of Cancer Education 14(3): 164-167, 1999

Assessing the impact of common bile duct resection in the surgical management of gallbladder cancer. Journal of Surgical Oncology 114(2): 176-180, 2016

HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. International Journal of Colorectal Disease 21(2): 135-142, 2006

MRI of anal cancer: assessing response to definitive chemoradiotherapy. Abdominal Imaging 39(1): 2, 2014

The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions. Cancer Causes and Control 23(2): 281-288, 2012

Anal acoustic reflectometry: a new technique for assessing anal sphincter function. Colorectal Disease 12(7): 692-697, 2010

Assessing the impact of neoadjuvant chemotherapy on the management of the breast and axilla in breast cancer. Clinical Breast Cancer 14(1): 20-25, 2014

Clinical and physiological evaluation of the anal function prognosis and managements for anal dysfunction following per anal anastomosis for lower rectal cancer. Journal Of The Japan Society Of Coloproctology: 378, 471, 1984